I see the milestone achievements as being independent of dilution, at least until we get closer to FDA-related milestones. I figure when we file for regulatory approval, PPS runs up enough for warrants to bring in some cash, and FDA or CE approval starts the real climb. Until then, who knows, but milestones haven't had the impact they should so far. Are we still being shorted to death? A plausible explanation, but I don't know enough about it to state that as fact.
I won't go quite so far as to say "Same rhetoric..." I think there is a grander plan to the PRs which I don't understand, combined with the legal side of what they can say which can't be construed as a performance claim for the device (which they can't state publicly until after regulatory approval). Given how tight-lipped they are about the device, I assume their legal team prefers to err on the side of caution. We don't get blindsided by violations and fines, but we also don't know nearly as much as we'd like to know.
Message in reply to:
Thanks. This is a hard one to figure out. It can be huge but not if they don't change. Thus far, same rhetoric, same. Same dilutions. Will that change? Not without a major milestone achievement